91 |
PREPARAÇÃO E CARACTERIZAÇÃO DE FILMES LbL DE FTALOCIANINA DE NÍQUEL E POLIELETRÓLITO SILSESQUIOXANOSantos, Cleverson Siqueira 13 March 2012 (has links)
Made available in DSpace on 2017-07-24T19:38:07Z (GMT). No. of bitstreams: 1
Cleverson S Santos.pdf: 2872449 bytes, checksum: 6d5838a843155793c2eb115ea3d233c4 (MD5)
Previous issue date: 2012-03-13 / Conselho Nacional de Desenvolvimento Científico e Tecnológico / The research focused on the development of electrochemical sensors based on LBL films have grown exponentially in recent years. In this context, this paper reports the development
of an electrochemical sensor using the Layer-by-layer (LbL) technique, which enables the construction of ultrathin films from electrostatic interactions between oppositely charged
polyelectrolytes. For this purpose, the tetrasulfonated nickel phthalocyanine (NiTsPc) was used as polyanion molecule and the 3-n-propilpyridinium silsesquioxane chloride (SiPy+Cl-)
as the polycation. This silsesquioxane polyelectrolyte is an excellent ion exchange and has high ability to form stable films on the surface of solid substrates. The LbL films were built using two different architectures: one with an outer layer of phthalocyanine designated as (SiPy+Cl-/NiTsPc)n and another with the phthalocyanine as the inner layer, (NiTsPc/SiPy+Cl-)n with different bilayers, (where n = number of bilayers). The deposition of the bilayers was monitored using the UV-VIS spectroscopy in the region from 500 to 800 nm, where the phthalocyanines exhibit two absorption bands, one related to the dimeric species at 630 nm and another at 669 nm related to monomeric form. It was observed that the parameters:immersion time, pH and concentration directly influenced the construction of these films and therefore they were optimized. The optimized parameters were: immersion time of 280 s, pH = 8 and concentrations of polyeletrolytes solutions of 2 mg mL-1, which provided stable and
homogeneous films, with higher concentrations of monomeric species. Monitoring the bilayers deposition in the UV-VIS region, a linear relationship was obtained between the
absorbance and the number of bilayers deposited. FTIR and Raman spectra showed that the interactions between the polyelectrolytes occurs by the SO3 groups in the structure of tetrasulfonated phthalocyanines with the pyridinium groups present in the structure of the SiPy+Cl-. Using the AFM technique, it was observed that the average roughness of the films decreased with the increase of bilayers. On the other hand, the thickness of the films increased with the number of bilayers, and the average thickness of each bilayer was 22 nm
for the architecture (SiPy+Cl-/NiTsPc)n, and 19.2 nm for the opposite configuration. The electrodes were applied for simultaneous determination of dopamine (DA) in the presence of the interfering species, such as ascorbic acid (AA) and uric (UA). It was observed that the architecture as well as the thickness of the films has influenced significantly the
electrochemical response in the presence of analytes. The film with the highest current density and less positive potential values for these analytes was (SiPy+Cl-/NiTsPc)2. For this electrode, f om the cyclic voltammetry technique, anodic peaks were observed at 0.30 V,0.68 V and 0.74 V in the presence of DA, AA and UA, respectively. Studies in different scan rates in presence of dopamine showed that the kinetics of electron transfer is controlled by diffusion of species to the electrode surface. Using the square wave voltammetry, DA was detected in presence of AA with a peak separation potential of 350 mV. However, for a fixed
concentration of DA, it was observed an increase of the intensity of peak current with increasing of AA concentration, which is an indication that the AA electrocatalyzes the
oxidation reaction of DA to dopaminequinone, causing an increase in the current, which prevents the accurate determination of these analytes simultaneously. On the other hand, in the presence of UA in a fixed concentration of 4.7 x 10-4 mol L-1, it was possible to quantify DA in the range of 1.0 x 10-5 to 9.9 x 10-5 mol L-1 with a detection limit of 2.37 x 10-6 mol L-1 and quantification limit of 7.9 x 10-6 mol L-1 with peak separation Ep= 500 mV. By varying both the concentration of DA and UA, in the range of 1.0 x 10-4 to 9.0 x 10-4 mol L-1 for DA and 1.0 x 10-5 to 9.9 x 10-5 mol L-1 for UA, it was obtained a correlation coefficient of R =
0.997 and R = 0.988 for AU and DA respectively. The results showed that the electrode (SiPy+Cl-/NiTsPc)2 is selective and sensitive for DA determination in presence of interfering
species AA and UA. / As pesquisas voltadas para o desenvolvimento de sensores eletroquímicos a base de filmes LbL têm crescido exponencialmente nos últimos anos. Neste âmbito, este trabalho relata o desenvolvimento de um sensor eletroquímico, utilizando a técnica Layer-by-Layer (LbL), a qual possibilita a construção de filmes ultrafinos a partir de interações eletrostáticas entre polieletrólitos de cargas opostas. Para tanto foi utilizado como poliânion a molécula ftalocianina tetrassulfonada de níquel (NiTsPc), e como policátion o cloreto de 3-npropilpiridínio silsesquioxano (SiPy+Cl-). Tal composto constitui um excelente trocador iônico, além de apresentar alta capacidade de formação de filmes estáveis sobre a superfície de substratos sólidos. Foram construídos filmes em duas arquiteturas: uma com a ftalocianina na camada mais externa designada como (SiPy+Cl-/NiTsPc)n e outra com esta na camada mais interna, (NiTsPc/SiPy+Cl-)n com diferentes bicamadas, (onde n= número de bicamadas). A deposição das bicamadas foi monitorada utilizando-se a técnica de espectroscopia de absorção na região do UV-VIS, mais precisamente na região de 500 a 800 nm, onde as ftalocianinas apresentam duas bandas de absorção, uma referente a forma agregada em 630 nm e outra referente a forma monomérica em 669 nm. Foi observado que as variáveis: tempo de imersão, pH e concentração dos polieletrólito influenciam diretamente na construção dos filmes e portanto estas foram otimizadas. Os parâmetros otimizados
foram: tempo de imersão de 280 s, pH = 8 e concentrações de 2 mg mL-1 obtendo-se filmes estáveis e homogêneos, com maiores concentrações de espécies monoméricas em relação
a espécies agregadas. O monitoramento da deposição das bicamadas na região do UV-VIS mostrou uma relação linear entre absorbância e o número de bicamadas depositadas. Os
espectros de FTIR e Raman, evidenciaram as interações entre os grupos SO3 presentes na estrutura das ftalocianinas tetrassulfonadas com os grupos piridínios presentes na estrutura do SiPy+Cl-. Utilizando a técnica de microscopia de força atômica foi possível verificar que a rugosidade média dos filmes diminuiu em função do aumento do número de bicamadas. Por outro lado, a espessura dos filmes aumentou com o número de bicamadas, sendo que a espessura média de cada bicamada foi de 22 nm para a configuração (SiPy+Cl-/NiTsPc)n, e de 19,2 nm para a configuração oposta. Os eletrodos foram aplicados na determinação simultânea de dopamina (DA) em meio aos interferentes ácido ascórbico (AA) e úrico (AU). Observou-se que a arquitetura assim como a espessura dos filmes influenciaram de maneira significativa na resposta eletroquímica na presença dos analitos. O filme que apresentou maior intensidade de corrente e valores de potencial de pico menos positivos foi (SiPy+Cl-/NiTsPc)2. Para este eletrodo, a partir da técnica de voltametria cíclica, foram
observados picos anódicos em 0,30 V, 0,68 V e 0,74 V, na presença de DA, AA e AU, respectivamente. Estudos da variação da velocidade de varredura para dopamina
mostraram que a cinética de transferência eletrônica é controlada pela difusão de espécies a superfície do eletrodo. Utilizando a técnica de voltametria de onda quadrada, detectou-se DA na presença de AA, com separação de potenciais de pico de 350 mV. No entanto, para uma concentração fixa de DA, foi observado um aumento da intensidade de corrente de pico com o aumento da concentração de AA, o que é um indicativo de que o AA eletrocatalisa a reação de oxidação de dopaminaquinona a DA novamente, o que impossibilita a determinação precisa destes analitos simultaneamente. Por outro lado, na presença de AU
com concentração fixa de 4,7 x 10-4 mol L-1, foi possível quantificar DA na faixa de 1,0 x 10-5 a 9,9 x 10-5 mol L-1 com limite de detecção de 2,4 x 10-6 mol L-1 e quantificação de 7,9 x 10-6 mol L-1 com separação de potencial de pico de 500 mV. Variando-se simultaneamente a concentração das duas espécies, DA e AU, na faixa de 1,0 x 10-4 a 9,0 x 10-4 mol L-1 para DA e 1,0 x 10-5 a 9,9 x 10-5 mol L-1 para AU, obteve-se coeficiente de correlação iguais a R = 0,997 e R = 0,988, para AU e DA respectivamente. Os resultados mostram que o eletrodo é seletivo e sensível a determinação de DA em meio aos interferentes AA e AU.
|
92 |
Funktionelle Genomanalyse des Purinverwerters Clostridium acidurici 9a / Functional genome analysis of the purine-utilizing bacterium Clostridium acidurici 9aHartwich, Katrin 05 December 2012 (has links)
No description available.
|
93 |
Výzkum sklivce a vitreoretinálního rozhraní u mikrovaskulárních chorob sítnice se zaměřením na oční komplikace diabetes mellitus. / Research of vitreous and vitreoretinal interface in microvascular retinal disorders focussed on eye complications of diabetes mellitusKřížová, Libuše January 2016 (has links)
In this work I present conclusions of clinical-laboratory research focused on the patients with diabetic macular edema (DME). We performed biochemical and immunochemical analyses of vitreous samples that were collected during the pars plana vitrectomy. Moreover, at patients with non-proliferative diabetic retinopathy (NPDR) we assessed morphological characteristics of DME using optical coherence tomography (OCT). According to our findings, the vitreous and serum concentrations of uric acid and glucose were significantly higher in patients with diabetic retinopathy and DME compared to controls. Also total ratio (serum/ vitreous concentration) of uric acid and glucose was in diabetics significantly higher than in controls. The most important determinant of increasing concentration of both uric acid and glucose in the vitreous was the grade of diabetic retinopathy. Moreover, we demonstrated significant correlation between vitreous concentration of uric acid and concentration of the vascular endothelial growth factor (VEGF) in patients with DME and NPDR. We found further, that the volume of the macula (cube volume - CV) computed with the software of Cirrus HD-OCT correlates in diabetics significantly with the vitreous VEGF concentration, but not with uric acid. This OCT parameter could be used to...
|
94 |
Rôle de l’acide urique dans la défaillance d’organes suite au choc hémorragique : une avenue thérapeutique?Khazoom, François 05 1900 (has links)
Introduction: Alors que le choc hémorragique représente la première cause de mortalité précoce chez les patients subissant un traumatisme sévère, la défaillance d’organes est responsable d’une mortalité tardive chez cette population. Les alarmines, molécules libérées en situation d’ischémie-reperfusion et capables d’induire une réponse inflammatoire systémique et locale, représentent potentiellement une cible thérapeutique afin de minimiser la défaillance d’organes post-traumatique. L’acide urique est une molécule pro-inflammatoire et pro-apoptotique libérée en situation de choc hémorragique dont les effets au niveau des organes sont peu investigués. Le premier volet de ce mémoire présente une preuve de concept que l’acide urique joue un rôle clé dans l’atteinte hépatique et intestinale dans un modèle animal de choc hémorragique, et sera présenté sous forme de manuscrit soumis. Le deuxième volet de ce mémoire présente des données préliminaires d’une étude clinique prospective visant à évaluer la cinétique de l’acide urique chez une cohorte de patients traumatisés.
Volet animal: Un choc hémorragique a été induit chez des rats Wistar en retirant du volume circulant titré à une tension artérielle moyenne (TAM) de 30-35 mmHg pendant 60 minutes. Les rats ont été réanimés avec une solution composée de sang retiré et de lactate ringer (1 :1), avec ou sans Uricase, une enzyme recombinante qui métabolise l’acide urique. Les résultats démontrent une diminution significative de plusieurs marqueurs d’hépatolyse (AST, ALT), inflammatoire (ICAM-1, MPO, TNF-alpha, IL-1, Caspase-1) et apoptotique (Caspase-3, -8, Bax/BCL-2, pAKT/AKT) au sein du groupe uricase. L’intervention sur l’acide urique a également pu prévenir l’augmentation de la perméabilité intestinale suite au choc hémorragique, de même que la translocation de produits bactériens en circulation (LPS).
Volet clinique: Vingt patients subissant un choc hémorragique traumatique ont été recrutés de façon prospective à l’Hôpital Sacré-Cœur de Montréal, dans le cadre d’un projet pilote soutenu par le consortium de trauma du FRSQ. Des prélèvements d’acide urique sérique ont été effectués de façon sériée pendant 7 jours. Les critères de faisabilité, notamment les taux de consentement (95%) et d’observance des prélèvements sériés (90% pour le premier prélèvement, 65% pour les prélèvements aux 4 heures, et 73% pour les prélèvements aux 8 heures) ont été jugés acceptables. Les cinétiques d’acide urique étaient reproductibles dans l’ensemble de la cohorte (R2 = 0.87). L’aire sous la courbe était significativement plus élevée chez les patients avec un score de défaillance d’organes plus élevé à 72h (SOFA6).
Conclusions: Bien que les mécanismes demeurent à élucider, ces travaux démontrent que l’acide urique est important médiateur dans l’atteinte des organes suivant un choc hémorragique. Cette molécule représente potentiellement une cible thérapeutique dont l’objectif ultime est de minimiser la défaillance d’organes suite au choc hémorragique. / While hemorrhagic shock is the first cause of early mortality among severe trauma patients, organ failure leads to late mortality and morbidity in this population. Alarmins, molecules released after ischemia-reperfusion, are able to activate local and systemic inflammatory pathways and potentially represent a therapeutic target to minimize organ failure. Uric acid is a pro-inflammatory and pro-apoptotic molecule released after hemorrhagic shock and its role pertaining to organ failure is incompletely studied. The first part of this thesis presents a proof of concept that uric acid plays a key role in liver and intestinal damage in an animal model of hemorrhagic shock; it will be presented in the format of a submitted article. The second part of this thesis presents preliminary data from a prospective observational clinical study evaluating uric acid kinetics in a cohort of trauma patients.
Animal study
Hemorrhagic shock was induced with blood withdrawal among Wistar rats for a target mean arterial blood pressure of 30-35 mmHg for 60 minutes. Animals were resuscitated with a 1 :1 mix of Ringer Lactate and drawn blood with or without Uricase, a recombinant enzyme that metabolizes uric acid. Results show a statistically significant decrease in hepatocellular damage (plasma AST and ALT), inflammatory markers (ICAM-1, MPO, TNF-alpha, IL-1, Caspase-1) and apoptotic markers (Caspase-3, -8, Bax/BCL-2, pAKT/AKT) among the Uricase group. The intervention on uric acid also prevented increased intestinal permeability and bacterial product (LPS) translocation. Clinical study
Twenty patients sustaining major trauma with hemorrhagic shock were prospectively recruited at Montreal Sacré-Cœur Hospital, in the context of a pilot study funded by the FRSQ trauma consortium. Uric acid concentration was determined serially for 7 days after trauma. Feasibility criteria, notably consent rate (95%), sampling observance rate (90% for first sample, 65% for samples every 4 hours, and 73% for samples every 8 hours) were considered acceptable. Uric acid kinetics were reproducible among the entire cohort (R2 = 0.87). The area under the curve was significantly increased among patients with higher sequential organ failure assessment score at 72h (SOFA³6).
Conclusions
Although mechanisms remain to be elucidated, these studies show that uric acid is an important mediator for the development of organ damage after hemorrhagic shock. This molecule potentially represents a therapeutic target with the ultimate goal of minimizing organ failure after hemorrhagic shock.
|
95 |
Výzkum sklivce a vitreoretinálního rozhraní u mikrovaskulárních chorob sítnice se zaměřením na oční komplikace diabetes mellitus. / Research of vitreous and vitreoretinal interface in microvascular retinal disorders focussed on eye complications of diabetes mellitusKřížová, Libuše January 2016 (has links)
In this work I present conclusions of clinical-laboratory research focused on the patients with diabetic macular edema (DME). We performed biochemical and immunochemical analyses of vitreous samples that were collected during the pars plana vitrectomy. Moreover, at patients with non-proliferative diabetic retinopathy (NPDR) we assessed morphological characteristics of DME using optical coherence tomography (OCT). According to our findings, the vitreous and serum concentrations of uric acid and glucose were significantly higher in patients with diabetic retinopathy and DME compared to controls. Also total ratio (serum/ vitreous concentration) of uric acid and glucose was in diabetics significantly higher than in controls. The most important determinant of increasing concentration of both uric acid and glucose in the vitreous was the grade of diabetic retinopathy. Moreover, we demonstrated significant correlation between vitreous concentration of uric acid and concentration of the vascular endothelial growth factor (VEGF) in patients with DME and NPDR. We found further, that the volume of the macula (cube volume - CV) computed with the software of Cirrus HD-OCT correlates in diabetics significantly with the vitreous VEGF concentration, but not with uric acid. This OCT parameter could be used to...
|
96 |
Inflammation d’origine non-pathogénique durant la gestation, implication dans les complications de la grossesse et impact sur le développement cérébralBrien, Marie-Ève 03 1900 (has links)
INTRODUCTION : Le retard de croissance intra-utérin (RCIU), la prééclampsie (PE) et l’accouchement prématuré (AP) sont d’importantes pathologies de la grossesse fortement associées à un mauvais fonctionnement du placenta, organe central au développement du fœtus. Environ 5-12% de toutes les grossesses sont pathologiques et ces dernières sont associées avec un risque accru de désordres neurodéveloppementaux chez l’enfant. L'inflammation est un point central à toutes les complications de la grossesse et le lien causal entre l’inflammation et ces pathologies a été démontré à l’aide de plusieurs modèles animaux d’inflammation prénatale, menant à des dommages cérébraux chez les nouveau-nés. Cependant, la majorité des modèles utilisent des stimuli infectieux, bien que des pathogènes soient rarement détectés en clinique. Malgré l'absence d'infection détectable, des évidences d'inflammation, telles que des niveaux élevés de cytokines pro-inflammatoires et d’alarmines, sont présentes. Les alarmines sont des médiateurs endogènes et une autre cause d'inflammation de plus en plus associée aux pathologies de la grossesse. L’acide urique est une des alarmines les plus étudiées comme médiateur endogène d’inflammation, mais son effet sur la grossesse est peu connu. Ainsi, mon hypothèse était que l’exposition prénatale particulièrement à l’acide urique serait associée aux complications de la grossesse, serait une cause de dommage placentaire et subséquemment altèrerait le neurodéveloppement fœtal, menant à des dommages cérébraux à long terme chez l’enfant.
Mon OBJECTIF général était de comprendre le lien entre inflammation prénatale non-pathogénique, les complications de la grossesse et les effets sur le placenta et le cerveau en développement. Spécifiquement, j’ai déterminé la présence d’inflammation dans les complications majeures de la grossesse puis je me suis concentré sur la PE et l’implication de l’activation immunitaire dans cette pathologie. En parallèle, j’ai établi le lien entre l’inflammation non-pathogénique, les dommages placentaires et le RCIU. Finalement, j’ai évalué le neurodéveloppement après l’exposition in-utero à une inflammation non-pathogénique et j’ai investigué le potentiel d’un nouveau traitement dans mon modèle préclinique.
MÉTHODOLOGIES ET RÉSULTATS: J’ai analysé le profil inflammatoire de 200 femmes avec ou sans complications de la grossesse (Ctrl, PE, AP, RCIU) et j’ai démontré que chaque complication présente un profil inflammatoire circulant distinct, particulièrement présent chez les femmes avec PE. De plus, j’ai analysé plus en profondeur les femmes avec PE et observé une augmentation d’acide urique dans la circulation maternelle, en lien avec un profil immunitaire qui était altéré et des changements structuraux au niveau du placenta. Pour déterminer les effets directs de l'acide urique, nous avons utilisé des cultures de trophoblastes primaires, cellule principale du placenta, et des explants placentaires humains. Nous avons démontré que l’acide urique induisait un profil pro-inflammatoire augmentant particulièrement la sécrétion d’IL-1β et d’IL-6 et induisait aussi l'apoptose des trophoblastes. En parallèle, j’ai développé un nouveau modèle préclinique de rates gestantes qui ont été injectées par voie intrapéritonéale avec l’acide urique du temps de gestation 18 (G18) à G21. L’injection d'acide urique in vivo à la fin de la gestation chez le rat a entrainé l’augmentation de cytokines (IL-1β, TNF-α et IL-6) et l’infiltration de cellules immunitaires dans le placenta ainsi qu’un RCIU chez le fœtus qui persistait dans la période postnatale. De plus, les bébés exposés in-utero à l’acide urique avaient une altération neurodéveloppementale caractérisée par l’activation microgliale et astrogliale en plus d’une diminution des capacités motrices. Ces effets de l’acide urique étaient dépendants de l'IL-1β et bloqués par l’antagoniste spécifique du récepteur de l’IL-1 (IL-1Ra).
CONCLUSIONS: L’inflammation est associée à toutes les complications de la grossesse, mais les profils diffèrent selon la pathologie étudiée. La PE est associée à des changements immunitaires importants. L'acide urique à l'interface materno-fœtale induit inflammation et altère les fonctions placentaires de façon IL-1-dépendante. Finalement, l’exposition à l’acide urique en fin de gestation chez le rat induit l’inflammation placentaire, le RCIU et altère le développement cérébral des bébés. Un traitement prénatal anti-inflammatoire permet de minimiser l’inflammation et ses effets négatifs sur le cerveau. / INTRODUCTION: Intra-uterine growth restriction (IUGR), preeclampsia (PE) and preterm birth (PTB) are important pathologies of pregnancy strongly associated with poor placental function, a central organ for fetal development. About 5-12% of all pregnancies are pathological and this increases the risk of neurodevelopmental disorders. Inflammation is central to all pregnancy complications and the causal link has been demonstrated with several animal models of prenatal inflammation leading to brain damage in newborns. However, these models use infectious stimuli although pathogens are rarely detected clinically. Despite the absence of detectable infection, evidence of inflammation, such as elevated levels of pro-inflammatory cytokines and alarmins, is observed. Alarmins are endogenous mediators, another cause of inflammation increasingly associated with pathological pregnancies. Uric acid is one of the most studied alarmins, however its effect on pregnancy is mostly unknown. Thus, my hypothesis was that prenatal exposure particularly to uric acid is associated with pregnancy complications and is a cause of placental damage which subsequently impairs fetal neurodevelopment, leading to long-term brain damage in the child.
My general OBJECTIVE was to understand the link between non-pathogenic prenatal inflammation, pregnancy complications and its effect on the placenta and the developing brain. Specifically, I detected the presence of inflammation in major pregnancy complications and subsequently focused on PE and its immune activation. In parallel, I established the causal link between non-infectious inflammation, placental damage and IUGR. Finally, I evaluated brain development following in utero inflammation and investigated a therapeutic target in my preclinical model.
METHODS AND RESULTS: I analyzed the inflammatory profile of 200 women with or without pregnancy complications (Ctrl, IUGR, PE, PTB) and demonstrated that each complication has a distinct circulating inflammatory profile, particularly in women with PE. In addition, I further analyzed women with PE and observed a uric acid increase in the maternal circulation, related to an altered immune profile and structural changes in the placenta. To determine the direct effects of uric acid, we used cultures of primary trophoblasts, the main cell of the placenta, and human placental explants. We have shown that uric acid induces a pro-inflammatory profile, particularly increasing the secretion of IL-1β and IL-6 and induces apoptosis of trophoblasts. In parallel, I developed a new preclinical model of pregnant rats that were injected intraperitoneally with uric acid from gestation time 18 (G18) to G21. The injection of uric acid at the end of gestation in the rat caused increase cytokines (IL-1β, TNF-α and IL-6), the infiltration of immune cells in the placenta as well as an IUGR in the fetus that persisted into the postnatal period. Additionally, babies exposed to uric acid in utero have neurodevelopmental impairment characterized by microglial and astroglial activation in addition to decreased motor function. These effects of uric acid was dependent on IL-1β and was blocked by the IL-1 receptor antagonist (IL-1Ra).
CONCLUSIONS: Inflammation is associated with all pregnancy complications, however, with different profiles depending on the pathology studied. PE is associated with significant immune changes. Uric acid at the maternal-fetal interface induced inflammation and altered placental functions in an IL-1-dependent manner. Ultimately, exposure to uric acid in late rat pregnancy induced placental inflammation, IUGR, and impaired brain development. Prenatal anti-inflammatory treatment helped minimize inflammation and these negative effects on the brain.
|
97 |
Stanovení vybraných komponent v lidské moči elektroforézou v krátké kapiláře. / Determination of selected components in human urine with electrophoresis in short capillary.Makrlíková, Anna January 2015 (has links)
Capillary zone electrophoresis is frequently used in various analyses. In this diploma thesis a hydrodynamic sample introduction method controlled by pressure pulse has been proposed for short-capillary electrophoresis. The base electrolyte flushes sample from the loop of a six-way sampling valve and is carried to the injection end of the capillary. At the time when the sample zone reached the capillary, a short pressure impulse is generated in the electrolyte stream, which provides injection of the sample into the capillary. Then the electrolyte flow is stopped and the separation voltage is turned on. The amount of sample introduced to the capillary is controlled by the duration of the pressure pulse. This new sample introduction method was tested in the determination of ammonia, histidine, creatinine, uric acid and hippuric acid in human urine and for rapid screening of the contents of the inorganic ions in cerebrospinal fluid and blood plasma. The determination was performed in a capillary with an overall length of 10,5 cm and two base electrolytes was tested - 50 mM MES + 5 mM NaOH (pH 5,10) and 1 M acetic acid + 1,5 mM crown ether 18-crown-6 (pH 2,40). Using dual detection techniques contactless conductivity and UV spectrometric detection, anorganic and organic substances in the sample could...
|
98 |
Investigation of the cross-talk between gut microbes and plasma metabolites in the development of post-traumatic epilepsyMäkinen, Nelly January 2024 (has links)
The aim of this project has been to investigate whether there are correlations to be found between gut microbes and serum metabolites, which could be involved in the development of epilepsy. To do so, metabolomics data containing metabolites and metagenomics data containing bacteria have been integrated and used in a pipeline utilizing the software package DIABLO in R Studio. DIABLO stands for Data Integration Analysis for Biomarker discovery using Latent cOmponents and utilizes multi-block pls-da to integrate multiple omics data sets to find potential biomarkers. The results in this project are mainly divided into two groups, the first group being from taking samples at an early time point, where subjects have not yet developed symptoms of epilepsy and the second group being from taking samples at a late time point, where the subjects have developed epilepsy. To find biomarkers in the data used for the integration, two subgroups are of highest interest, namely subgroup PTE, which is the group that develops epilepsy symptoms after an induced trauma to the brain, as well as subgroup TBI which do not develop epilepsy symptoms after an induced trauma to the brain. Results from the early time point suggests that bacteria such as those from Phelethenecus, Christenselellales, Ventrimonas, Ruminococcaceae and Acetatifactor, as well as metabolites such as LPC 17:0, Indole and Indole-3-carboxyaldehyde might be of interest in finding biomarkers previous to the development of epilepsy after induced brain trauma. Results from the late time point suggests that bacteria such as those from Muribaculaceae and Avidehalobacter, as well as metabolites such as Dioctyl sulfosuccinate, Canrenone, LPC 18:0, Uric acid, Arjunolic acid and Pseudouridine might be of interest in finding underlying mechanisms behind the existing condition of epilepsy. The hope is that findings in this paper might aid in future development of knowledge behind this disease as well as its underlying mechanisms.
|
Page generated in 0.4039 seconds